Similar mechanisms are also identified for recombinant tau fibrils, pathological tau in Alzheimer’s disease (AD), and other tauopathies [18,19,20,21,22,23,24,25,26,27,28,29,30,31,32,33,34,35,36,37]. The gene discussed is MAPT; the disease is tauopathy.